HLB Pharmaceutical (047920.KQ) Earnings Analysis
HLB Pharmaceutical (047920.KQ) has no confirmed upcoming earnings date. Trailing P/E 70.99.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 047920.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 047920.KQ. This page updates as the calendar is published.
047920.KQ earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
047920.KQ valuation and analyst view
| Trailing P/E | 70.99 |
|---|---|
| Trailing EPS | 113.52 KRW |
| Price / book | 1.74 |
| Dividend yield | 0.00% |
| Market cap | 262.39B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is HLB Pharmaceutical (047920.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 047920.KQ. This page updates as the calendar is published.
What is 047920.KQ's current P/E ratio and EPS?
047920.KQ trades at a trailing P/E of 70.99 on trailing EPS of 113.5226639815733 KRW.
What do analysts rate 047920.KQ?
047920.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.